Mountain View, Calif.-based Neuropace Inc. is looking to take on a new challenge with its closed-loop neuromodulation technology. To that end, a study will examine whether its responsive neurostimulation (RNS) system could help in managing loss-of-control eating in patients with a body mass index of 45-60 kg/m2 for whom medication and gastric bypass surgery have not proven effective.